125 related articles for article (PubMed ID: 28353247)
1. Combining Patient-Reprogrammed Neural Cells and Proteomics as a Model to Study Psychiatric Disorders.
Zuccoli GS; Martins-de-Souza D; Guest PC; Rehen SK; Nascimento JM
Adv Exp Med Biol; 2017; 974():279-287. PubMed ID: 28353247
[TBL] [Abstract][Full Text] [Related]
2. Application of iTRAQ Shotgun Proteomics for Measurement of Brain Proteins in Studies of Psychiatric Disorders.
Núñez EV; Guest PC; Martins-de-Souza D; Domont GB; Nogueira FC
Adv Exp Med Biol; 2017; 974():219-227. PubMed ID: 28353239
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Profiling of the Pituitary Gland in Studies of Psychiatric Disorders.
Krishnamurthy D; Rahmoune H; Guest PC
Adv Exp Med Biol; 2017; 974():313-319. PubMed ID: 28353251
[TBL] [Abstract][Full Text] [Related]
4. Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds.
Montgomery A; Wong A; Gabers N; Willerth SM
Biomater Sci; 2015 Feb; 3(2):401-13. PubMed ID: 26218131
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of acellular embryonic matrices on pluripotent stem cell expansion and neural differentiation.
Yan Y; Martin LM; Bosco DB; Bundy JL; Nowakowski RS; Sang QX; Li Y
Biomaterials; 2015 Dec; 73():231-42. PubMed ID: 26410789
[TBL] [Abstract][Full Text] [Related]
6. Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells.
Kim SY; Kim MJ; Jung H; Kim WK; Kwon SO; Son MJ; Jang IS; Choi JS; Park SG; Park BC; Han YM; Lee SC; Cho YS; Bae KH
Stem Cells Dev; 2012 May; 21(8):1272-86. PubMed ID: 21787230
[TBL] [Abstract][Full Text] [Related]
7. SILAC Mass Spectrometry Profiling: A Psychiatric Disorder Perspective.
Duque-Guimarães D; Ong TP; de Almeida-Faria J; Guest PC; Ozanne SE
Adv Exp Med Biol; 2017; 974():289-298. PubMed ID: 28353248
[TBL] [Abstract][Full Text] [Related]
8. Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds.
Ye J; Ge J; Zhang X; Cheng L; Zhang Z; He S; Wang Y; Lin H; Yang W; Liu J; Zhao Y; Deng H
Cell Res; 2016 Jan; 26(1):34-45. PubMed ID: 26704449
[TBL] [Abstract][Full Text] [Related]
9. A Two-Dimensional Difference Gel Electrophoresis (2D-DIGE) Protocol for Studies of Neural Precursor Cells.
Guest PC
Adv Exp Med Biol; 2017; 974():183-191. PubMed ID: 28353235
[TBL] [Abstract][Full Text] [Related]
10. Derivation of Neural Stem Cells from Mouse Induced Pluripotent Stem Cells.
Karanfil I; Bagci-Onder T
Methods Mol Biol; 2016; 1357():329-38. PubMed ID: 25863785
[TBL] [Abstract][Full Text] [Related]
11. Defining pluripotent stem cells through quantitative proteomic analysis.
Reiland S; Salekdeh GH; Krijgsveld J
Expert Rev Proteomics; 2011 Feb; 8(1):29-42. PubMed ID: 21329426
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
14. SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence.
Winiecka-Klimek M; Smolarz M; Walczak MP; Zieba J; Hulas-Bigoszewska K; Kmieciak B; Piaskowski S; Rieske P; Grzela DP; Stoczynska-Fidelus E
PLoS One; 2015; 10(11):e0141688. PubMed ID: 26535892
[TBL] [Abstract][Full Text] [Related]
15. Derivation of Skeletal Myogenic Precursors from Human Pluripotent Stem Cells Using Conditional Expression of PAX7.
Darabi R; Perlingeiro RC
Methods Mol Biol; 2016; 1357():423-39. PubMed ID: 25403466
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
17. Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases.
Adegbola A; Bury LA; Fu C; Zhang M; Wynshaw-Boris A
Stem Cells Transl Med; 2017 Dec; 6(12):2062-2070. PubMed ID: 29027744
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cells: Generation, Characterization, and Differentiation--Methods and Protocols.
Graversen VK; Chavala SH
Methods Mol Biol; 2016; 1357():395-401. PubMed ID: 25403469
[TBL] [Abstract][Full Text] [Related]
19. Proteomic Profiling of Skin Fibroblasts as a Model of Schizophrenia.
Wang L; Rahmoune H; Guest PC
Adv Exp Med Biol; 2017; 974():305-311. PubMed ID: 28353250
[TBL] [Abstract][Full Text] [Related]
20. LC-MS
Fioramonte M; Guest PC; Martins-de-Souza D
Adv Exp Med Biol; 2017; 974():115-129. PubMed ID: 28353228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
